or Try an Advanced Search...

    Technical Analysis for MLYS - Mineralys Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 12.17 4.02% 0.47
    MLYS closed up 4.02 percent on Monday, July 1, 2024, on approximately normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical MLYS trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Stochastic Buy Signal Bullish 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Up 3 Days in a Row Strength 0.00%
    Pocket Pivot Bullish Swing Setup 4.02%
    Volume Surge Other 4.02%
    Lower Bollinger Band Walk Weakness 4.02%
    Lower Bollinger Band Touch Weakness 4.02%
    Oversold Stochastic Weakness 4.02%
    Lower Bollinger Band Walk Weakness 5.83%
    Older End-of-Day Signals for MLYS ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 9 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    Rose Above 10 DMA about 10 hours ago
    Rose Above Previous Day's High about 10 hours ago
    10 DMA Resistance about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    MLYS Chart by TradingView
    Basic chart:

    Profile

    Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Clinical Medicine Hypertension Cardiovascular Disease Treatment Of Hypertension

    Is MLYS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 21 Insider Sale: CEO Jon Congleton Sells Shares of Mineralys Therapeutics Inc (MLYS)
    Jun 15 Mineralys Therapeutics Inc (MLYS) CEO Jon Congleton Sells 72,797 Shares
    Jun 14 Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors
    Jun 14 Insider Sale: CFO and Secretary Adam Levy Sells 96,815 Shares of Mineralys Therapeutics Inc (MLYS)
    Jun 3 Mineralys Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    May 13 Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2024 Earnings Call Transcript
    May 13 We Think Mineralys Therapeutics (NASDAQ:MLYS) Can Afford To Drive Business Growth
    May 11 Mineralys Therapeutics, Inc. (MLYS) Q1 2024 Earnings Call Transcript
    May 9 Mineralys Therapeutics GAAP EPS of -$0.70 misses by $0.03
    May 9 Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
    See more MLYS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.905
    52 Week Low 5.86
    Average Volume 196,217
    200-Day Moving Average 10.90
    50-Day Moving Average 12.58
    20-Day Moving Average 12.48
    10-Day Moving Average 11.90
    Average True Range 0.62
    RSI (14) 48.19
    ADX 16.44
    +DI 21.55
    -DI 24.12
    Chandelier Exit (Long, 3 ATRs) 11.81
    Chandelier Exit (Short, 3 ATRs) 12.90
    Upper Bollinger Bands 13.85
    Lower Bollinger Band 11.10
    Percent B (%b) 0.39
    BandWidth 22.04
    MACD Line -0.28
    MACD Signal Line -0.22
    MACD Histogram -0.063
    Fundamentals Value
    Market Cap 500.25 Million
    Num Shares 41.1 Million
    EPS -1.38
    Price-to-Earnings (P/E) Ratio -8.82
    Price-to-Sales 0.00
    Price-to-Book 2.18
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 13.12
    Resistance 3 (R3) 13.07 12.72 12.96
    Resistance 2 (R2) 12.72 12.48 12.74 12.90
    Resistance 1 (R1) 12.44 12.33 12.58 12.49 12.85
    Pivot Point 12.09 12.09 12.16 12.11 12.09
    Support 1 (S1) 11.81 11.85 11.95 11.86 11.49
    Support 2 (S2) 11.46 11.70 11.48 11.44
    Support 3 (S3) 11.18 11.46 11.38
    Support 4 (S4) 11.23